Picture of Amoeba SA logo

ALMIB Amoeba SA News Story

0.000.00%
fr flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

Brief: Amoeba: Final Stages Of Development Of 100% Biocontrol Plant In Cavaillon

Sept 22 (Reuters) - Amoeba SA  ALMIB.PA :
    * AMOEBA: FINAL STAGES OF DEVELOPMENT OF 100% BIOCONTROL
PLANT IN
CAVAILLON
    * VIEW TO MARKETING ITS BIOCONTROL SOLUTIONS IN EARLY 2025
    * ONCE THESE FINAL STAGES HAVE  BEEN COMPLETED, WORK SHOULD
START
IN THE 4TH QUARTER OF 2023
    * THIS MAJOR  INDUSTRIAL PROJECT, EXPECTED TO COST AROUND
€45
MILLION OVER THE PERIOD 2023-2025 (€23 MILLION IN  CAPITAL
EXPENDITURE AND €22 MILLION IN OPERATING EXPENSES), IS ALREADY
BEING SUPPORTED BY BPI FRANCE TO THE AMOUNT OF €5.9 MILLION AS
PART OF THE FRANCE 2030 PROGRAM
    * HAS ALSO ANNOUNCED A €9  MILLION FINANCING IN THE FORM OF
SIMPLE
BONDS WITH THE SWISS COMPANY NICE & GREEN
    * SIGNING OF THE DEED OF SALE, I.E. THE FINAL PURCHASE OF
THE 
LAND, IS SCHEDULED FOR SEPTEMBER 26

Source text for Eikon:  ID:nNDLcb8rXz 
Further company coverage:  ALMIB.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Amoeba SA

See all news